Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6045116 | 1.00 | — | — | |
| SCHEMBL31694328 | 1.00 | CA2 (0.37) | CA2 | |
| SCHEMBL30445495 | 1.00 | CA2 (0.37) | CA2 | |
| SCHEMBL354725 | 1.00 | CA2 (0.37) | CA2 | |
| SCHEMBL1534459 | 1.00 | CA2 (0.37) | CA2 | |
| SCHEMBL31694358 | 1.00 | CA2 (0.37) | CA2 | |
| SCHEMBL23647292 | 0.83 | CA2 (0.44) | CA2 | |
| SCHEMBL1573071 | 0.83 | MEN1 (0.38) | — | |
| SCHEMBL4607864 | 0.83 | CA2 (0.44) | CA2 | |
| SCHEMBL10835191 | 0.83 | CA2 (0.44) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250041459-A1 | Polyethylene Glycol Modified Zwitterionic Fluorescent Probe and Application Thereof, and Preparation | Beijing Sonophotonano Medical Technology Company Limited (CN) | 2025-02-06 | — | — | US | disclosed |
| EP-4484522-A1 | POLYETHYLENE GLYCOL MODIFIED ZWITTERIONIC FLUORESCENT PROBE AND APPLICATION THEREOF, AND PREPARATION | Beijing Sonophotonano Medical Technology Company Limited (CN) | 2025-01-01 | — | — | EP | disclosed |
| US-20240360088-A1 | WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2024-10-31 | — | — | US | disclosed |
| US-12102633-B2 | Spirolactone compounds | QUIXGEN, INC. (US) | 2024-10-01 | — | — | US | disclosed |
| EP-4367104-A1 | WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING | Oregon Health & Science University (US) | 2024-05-15 | — | — | EP | disclosed |
| US-20240140909-A1 | HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN (US) | 2024-05-02 | — | — | US | disclosed |
| EP-3644998-B1 | NOVEL SPIROLACTONE COMPOUNDS | QUIXGEN INC (US) | 2024-04-10 | — | — | EP | disclosed |
| CN-117677610-A | Water-soluble neuro-dyes for in vivo neural specific imaging | 俄勒冈健康与科学大学 | 2024-03-08 | — | — | CN | disclosed |
| US-20230382857-A1 | HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS | CHILDREN'S NATIONAL MEDICAL CENTER (US) | 2023-11-30 | — | — | US | disclosed |
| US-20230355609-A1 | Spirolactone Compounds | QUIXGEN, INC. (US) | 2023-11-09 | — | — | US | disclosed |
| US-20080214630-A1 | Oral bioavailability; minimal toxicity; low concentration in the kidneys after administration; reduce oxidative stress; (S)-4,5-Dihydro-2-[2-hydroxy-4-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]-4-methyl-4-thiazolecarboxylic acid; condition responsive to chelation or sequestration of a trivalent metal | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2008-09-04 | — | — | US | disclosed |
| CN-101189216-A | Desferrithiocin polyether analogues | UNIV FLORIDA (US) | 2008-05-28 | — | — | CN | disclosed |
| WO-2008060534-A1 | PRINTABLE THIN-FILM TRANSISTORS WITH HIGH DIELECTRIC CONSTANT GATE INSULATORS AND METHODS FOR PRODUCING SAME | GEORGIA TECH RESEARCH CORPORATION (US) | 2008-05-22 | — | — | WO | disclosed |
| EP-1888311-A2 | COATED METAL OXIDE NANOPARTICLES AND METHODS FOR PRODUCING SAME | GEORGIA TECH RESEARCH CORPORATION (US) | 2008-02-20 | — | — | EP | disclosed |
| EP-1866296-A1 | DESFERRITHIOCIN POLYETHER ANALOGUES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2007-12-19 | — | — | EP | disclosed |
| WO-2006124670-A2 | COATED METAL OXIDE NANOPARTICLES AND METHODS FOR PRODUCING SAME | GEORGIA TECH RESEARCH CORPORATION (US) | 2006-11-23 | — | — | WO | disclosed |
| WO-2006107626-A1 | DESFERRITHIOCIN POLYETHER ANALOGUES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2006-10-12 | — | — | WO | disclosed |
| EP-0772607-A1 | WATER-SOLUBLE METHINE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING THE SAME | FUJI PHOTO FILM CO., LTD. (JP) | 1997-05-14 | — | — | EP | disclosed |
| US-5599825-A | ANTITUMOR AGENTS | FUJI PHOTO FILM CO., LTD. (JP) | 1997-02-04 | — | — | US | disclosed |
| WO-1996003393-A1 | WATER-SOLUBLE METHINE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING THE SAME | FUJI PHOTO FILM CO., LTD. (JP) | 1996-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240140909-A1 | HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS | CD68, HCCS, NR1H4 | CA2 1490/4885 |
| US-20080214630-A1 | Oral bioavailability; minimal toxicity; low concentration in the kidneys after administration; reduce oxidative stress; (S)-4,5-Dihydro-2-[2-hydroxy-4-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]-4-methyl-4-thiazolecarboxylic acid; condition responsive to chelation or sequestration of a trivalent metal | SLC7A1, SLC19A1, SLC10A6 | CA2 137/4885 |
| US-20230382857-A1 | HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS | CD68, HCCS, NR1H4 | CA2 1490/4885 |
| US-20230355609-A1 | Spirolactone Compounds | ACACA, AKR1C2, AKR1A1 | CA2 2346/4885 |
| US-12102633-B2 | Spirolactone compounds | ACACA, AKR1C2, AKR1A1 | CA2 2346/4885 |
| US-20250041459-A1 | Polyethylene Glycol Modified Zwitterionic Fluorescent Probe and Application Thereof, and Preparation | EGFR, ALK, CD44 | CA2 944/4885 |
| US-20240360088-A1 | WATER-SOLUBLE NERVE DYES FOR IN VIVO NERVE-SPECIFIC IMAGING | PAX8, GAP43, PAX2 | CA2 2720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.